ROC results in Table 1 display that PPP4C levels had high predictive accuracy in 14 tumor types, including BLCA, BRCA, cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), CHOL, COAD, glioblastoma multiforme (GBM), LAML, brain lower grade glioma (LGG), ovarian serous cystadenocarcinoma (OV), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), STAD, uterine corpus endometrial carcinoma (UCES), and uterine carcinosarcoma (USC). Here, PPP4C is linked to endocervical adenocarcinoma.